Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-03-26CYBNSCHEDULE 13GSchedule 13G Filing for Cybin Inc.MEDIUM
Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, have filed a Schedule 13G regarding their beneficial ownership of Cybin Inc. Common Shares. As of March 19, 2026, these reporting persons collectively owned 2,397,721 shares, representing 4.8% of the outstanding shares. This ...
Biotechnologyownership +4.80%
2026-03-26CYBIN INC.SCHEDULE 13GSchedule 13G Filing for Cybin Inc.DuplicateMEDIUM
Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, have filed a Schedule 13G regarding their beneficial ownership of Cybin Inc. Common Shares. As of March 19, 2026, these reporting persons collectively owned 2,397,721 shares, representing 4.8% of the outstanding shares. This ...
Biotechnologyownership +4.80%
2026-03-25RVPHWSCHEDULE 13GAmendment to Schedule 13G Filing for Reviva Pharmaceuticals Holdings, Inc.MEDIUM
CVI Investments, Inc. and Heights Capital Management, Inc. have jointly filed an amendment to their Schedule 13G, reporting beneficial ownership of Reviva Pharmaceuticals Holdings, Inc. common stock. CVI Investments, Inc. holds 666,667 shares, representing 5.2% of the outstanding stock. Heights Capital Management, Inc....
Biotechnologyownership +5.20%
2026-03-25CVI Investments, Inc.SCHEDULE 13GAmendment to Schedule 13G Filing for Reviva Pharmaceuticals Holdings, Inc.DuplicateMEDIUM
CVI Investments, Inc. and Heights Capital Management, Inc. have jointly filed an amendment to their Schedule 13G, reporting beneficial ownership of Reviva Pharmaceuticals Holdings, Inc. common stock. CVI Investments, Inc. holds 666,667 shares, representing 5.2% of the outstanding stock. Heights Capital Management, Inc....
Biotechnologyownership +5.20%